Indegene Stock Screener | Share Price & Fundamental Analysis
INDGN
Healthcare Technology
Screen Indegene share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹522.60
▲
1.85 (0.36%)
Share Price BSE
₹522.05
▲
1.30 (0.25%)
Market Cap
₹12,504.07 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
4.38
EPS (TTM)
₹17.15
Dividend Yield
0.38%
Debt to Equity
0.15
52W High
₹673.75
52W Low
₹503.95
Operating Margin
20.00%
Profit Margin
15.11%
Revenue (TTM)
₹781.00
EBITDA
₹173.00
Net Income
₹118.00
Total Assets
₹3,326.00
Total Equity
₹2,616.00
Indegene Share Price History - Stock Screener Chart
Screen INDGN historical share price movements with interactive charts. Analyze price trends and patterns.
Indegene Company Profile - Fundamental Screener
Screen Indegene company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for INDGN shares.
Indegene Limited is a global provider of digital-led commercialization services for the life sciences industry. The company offers solutions in analytics, technology, and commercial, medical, regulatory, and safety services to biopharmaceutical, emerging biotech, and medical devices companies. Indegene operates through four main segments: Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Others. These segments assist with digital marketing operations, last-mile promotion optimization, regulatory and medical operations consolidation, and clinical solutions and consultancy services. The company has made several acquisitions to expand its capabilities, including Encima Group, DT Associates, Cult Health, and Trilogy Writing & Consulting GmbH. In 2023, Indegene launched Invisage, an AI-enabled hybrid omnichannel sales and marketing platform. The company completed a public issue in May 2024, raising funds through a fresh issue and offer for sale.
Sector
Healthcare
Industry
Healthcare Technology
Sub-Sector
Healthcare Technology
Segment
E
Chairperson/CEO
Manish Gupta
ISIN
INE065X01017
Website
https://www.indegene.com
Indegene Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen INDGN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 3,326 | 2,546 | 2,204 | 1,354 | 596 | 600 | 329 |
| Current Assets | 2,530 | 1,791 | 1,449 | 1,130 | 459 | 418 | 185 |
| Fixed Assets | 678 | 646 | 664 | 138 | 86 | 119 | 104 |
| Liabilities | |||||||
| Total Liabilities | 3,326 | 2,546 | 2,204 | 1,354 | 596 | 600 | 329 |
| Current Liabilities | 146 | 506 | 651 | 149 | 64 | 369 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 2,616 | 1,429 | 1,064 | 764 | 333 | -16 | 152 |
| Share Capital | 48 | 44 | 44 | 0 | 0 | 0 | 79 |
| Reserves & Surplus | 2,567 | 1,385 | 1,020 | 764 | 324 | -105 | 73 |
Screen INDGN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 781 | 783 | 824 | 699 | 699 | 708 | 758 | 645 | 636 | 647 | 687 | 540 |
| Expenses | 608 | 606 | 664 | 534 | 548 | 561 | 589 | 535 | 511 | 515 | 525 | 413 |
| EBITDA | 173 | 177 | 160 | 164 | 151 | 148 | 170 | 111 | 125 | 133 | 162 | 127 |
| Operating Profit % | 20.00% | 20.00% | 17.00% | 21.00% | 19.00% | 18.00% | 18.00% | 15.00% | 16.00% | 19.00% | 22.00% | 21.00% |
| Depreciation | 21 | 22 | 23 | 19 | 20 | 19 | 20 | 20 | 20 | 20 | 18 | 10 |
| Interest | 3 | 4 | 4 | 12 | 12 | 4 | 3 | 12 | 13 | 12 | 12 | 2 |
| Profit Before Tax | 149 | 152 | 133 | 134 | 120 | 124 | 146 | 79 | 93 | 101 | 132 | 115 |
| Tax | 32 | 36 | 31 | 39 | 32 | 32 | 37 | 30 | 24 | 26 | 34 | 29 |
| Net Profit | 118 | 116 | 102 | 95 | 88 | 92 | 110 | 49 | 68 | 75 | 99 | 86 |
| EPS | 4.91 | 4.86 | 4.26 | 4.27 | 3.79 | 3.84 | 4.59 | 2.20 | 3.09 | 3.38 | 4.45 | 3.88 |
Indegene Cash Flow Screener - Liquidity Fundamentals
Screen INDGN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 442 | 508 | 130 | 297 | 172 | 22 | 65 |
| Investing Activities | -677 | -327 | -896 | -158 | -81 | -16 | -18 |
| Financing Activities | 288 | -66 | 333 | 234 | -132 | 136 | -21 |
| Net Cash Flow | 52 | 115 | -433 | 373 | -41 | 143 | 25 |
Screen INDGN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-May | 2024-Apr |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 11.30% | 10.05% | 5.24% | 5.03% | 4.82% | 3.79% | 0.00% | 0.00% |
| DII Holding | 6.96% | 7.20% | 4.96% | 3.98% | 3.17% | 3.84% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 13.28% | 13.51% | 11.34% | 26.41% | 24.32% | 24.67% | 0.00% | 0.00% |
| Other Holding | 68.46% | 69.24% | 78.45% | 64.58% | 67.69% | 67.70% | 100.00% | 100.00% |
| Shareholder Count | 151,809 | 151,997 | 144,708 | 153,789 | 151,440 | 203,599 | 82 | 82 |
Indegene Dividend Screener - Share Yield Analysis
Screen INDGN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹2.00 | 0.38% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Indegene Index Membership - Market Screener Classification
Screen INDGN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Indegene Market Events Screener - Corporate Actions
Screen INDGN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 9.73% | ||
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -1.67% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | -2.22% |
| 2025-06-26 | 2025-06-26 | Annual General Meeting | NA | -4.70% |
| 2025-06-13 | 2025-06-13 | Dividend | ₹ 2.00 /share | 5.49% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | -0.50% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -6.18% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 3.40% |
| 2022-11-17 | 2022-11-17 | Change Of Name | NA | - |
Indegene Competitors Screener - Peer Comparison
Screen INDGN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Syngene International | 25,939 | 56.30 | 3,714 | 3.77% | 496 | 47.49 |
| Indegene | 12,504 | 28.17 | 2,947 | 10.53% | 407 | 43.48 |
| Suven Life Sciences | 3,809 | -17.51 | 18 | -46.34% | -161 | 43.11 |
| Vimta Labs | 2,658 | 43.83 | 322 | 0.22% | 41 | 42.43 |
| Take Solutions | 586 | 11.76 | 10 | 126.67% | 1 | 86.68 |
| Bilcare | 184 | -4.18 | 807 | 4.78% | -56 | 42.36 |
| Jeevan Scientific Technology | 103 | -22.20 | 48 | 17.87% | 0 | 67.46 |
| Adeshwar Meditex | 26 | 33.09 | 84 | 5.00% | 2 | 21.98 |
| Vanta Bioscience | 16 | -1.10 | 2 | -78.57% | -13 | 51.57 |
Indegene Company Announcements - News Screener
Screen INDGN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-06 | Closure of Trading Window | View |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-30 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-12-19 | Announcement under Regulation 30 (LODR)-Change in Directorate | View |
| 2025-11-26 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-11-03 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-01 | Intimation Of Opening Of Trading Window | View |
| 2025-11-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-10-31 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-10-30 | Disclosure Under SEBI (LODR) Regulations 2015 - Investment In Wholly Owned Subsidiary | View |
| 2025-10-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-10-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-10-30 | Disclosure Under Regulation 30 Of SEBI(LODR) Regulations 2015 - Intimation Of Grant | View |
| 2025-10-30 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-10-30 | Outcome Of Board Meeting - Q2FY26 Results | View |